TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 19307354

Group type: EXPERIMENTAL
Intervention: Intravenous cloxacillin for 6 weeks plus 2 weeks orally (p.o.)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Oral rifampin‐cotrimoxazole for 8 weeks p.o.
Number of subjects: 50

Group type: COMPARATOR
Intervention: Foreign-body maintenance
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Oral rifampin‐cotrimoxazole
Number of subjects: 50
Study: 17325405

Group type: EXPERIMENTAL
Intervention: Lay‐led self care support group (6‐weekly sessions to teach self care skills)
Number of subjects: 629

Group type: COMPARATOR
Intervention: Waiting list control
Number of subjects: 629
Study: 15038927

Group type: EXPERIMENTAL
Intervention: Evidence-based treatment
Number of subjects: 542

Group type: EXPERIMENTAL
Intervention: Adjunctive therapies and combination medications
Number of subjects: 542

Group type: EXPERIMENTAL
Intervention: Service use
Number of subjects: 542
Study: 11351771

Group type: EXPERIMENTAL
Intervention: Insulin lispro (LP) combined with insulin lispro protamine suspension (NPL)
Number of subjects: 166

Group type: COMPARATOR
Intervention: Regular human insulin (HR) combined with human NPH insulin (NPH)
Number of subjects: 166
Study: 9684796

Group type: EXPERIMENTAL
Intervention: Low dose TNFR:Fc (10 mg/m2 i.v., n = 6)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: High dose TNFR:Fc (60 mg/m2 i.v., n = 6)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Vehicle (placebo, n = 6)
Number of subjects: 18
Study: 7802318

Group type: EXPERIMENTAL
Intervention: Electro‐medicamentous anesthesia after Kastrubin‐Kordyukov, n = 24
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Electro‐medicamentous anesthesia after Limoges' technique modified by M.I. Kuzin et al., n = 21
Number of subjects: 88

Group type: COMPARATOR
Intervention: Combined anesthesia based on NLA agents and placebo (simulated transcerebral electropulse exposure), n = 14
Number of subjects: 88

Group type: COMPARATOR
Intervention: Combined NLA anesthesia (controls), n = 29
Number of subjects: 88
Study: 2657207

Group type: EXPERIMENTAL
Intervention: Chlorophyllypt (0.25% solution in physiological sodium chloride solution administered by intravenous drip)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Traditional antibiotic therapy
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Chlorophyllypt
Number of subjects: 22

Group type: COMPARATOR
Intervention: Broad-action antibiotics
Number of subjects: 22
Study: 30835495

Group type: EXPERIMENTAL
Intervention: Insomnia
Number of subjects: 2620

Group type: EXPERIMENTAL
Intervention: Daytime sleepiness
Number of subjects: 2620

Group type: EXPERIMENTAL
Intervention: Long sleepers
Number of subjects: 2620
Study: 29432877

Group type: EXPERIMENTAL
Intervention: Vitamin D and probiotic co-supplementation (50,000 IU vitamin D every 2 weeks plus 8 × 10^9 CFU/g probiotic)
Number of subjects: 60
Study: 27473162

Group type: EXPERIMENTAL
Intervention: Anterior approach ISB with 15 ml of ropivacaine 1%
Number of subjects: 84

Group type: COMPARATOR
Intervention: Posterior approach ISB with 15 ml of ropivacaine 1%
Number of subjects: 84
Study: 24521425

Group type: EXPERIMENTAL
Intervention: Ritonavir-boosted lopinavir (LPV/r)
Number of subjects: 323

Group type: COMPARATOR
Intervention: Nevirapine-based ART
Number of subjects: 323
Study: 23530767

Group type: EXPERIMENTAL
Intervention: Active probiotic (Lactobacillus acidophilus, Lactobacillus rhamnosus, Bifidobacterium bifidum and Streptococcus faecium)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107
Study: 20887495

Group type: EXPERIMENTAL
Intervention: 400 mg daily of pyridoxine
Number of subjects: 56

Group type: COMPARATOR
Intervention: 200 mg daily of pyridoxine
Number of subjects: 56
Study: 18412725

Group type: EXPERIMENTAL
Intervention: Three-cornered flap technique (group A)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Distal wedge flap technique (group B)
Number of subjects: 20
Study: 15702341

Group type: EXPERIMENTAL
Intervention: Strength training (24-week program, twice per week, consisting of calf-rise and leg-press exercises at 75% of three-repetition maximum)
Number of subjects: 0
Study: 12197572

Group type: EXPERIMENTAL
Intervention: Budesonide 64 microg
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Budesonide 256 microg
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Mometasone furoate 200 microg
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study: 10194002

Group type: EXPERIMENTAL
Intervention: Acoustic stimuli processed from friction sounds picked up by microphones on fingers of nonsensate hands or prostheses.
Number of subjects: 9
Study: 7775054

Group type: EXPERIMENTAL
Intervention: Letter patterns
Number of subjects: 74

Group type: COMPARATOR
Intervention: Non-letter patterns
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Letter stimuli
Number of subjects: 74

Group type: COMPARATOR
Intervention: Non-letter stimuli
Number of subjects: 74
Study: 2107994

Group type: EXPERIMENTAL
Intervention: Systemic antibiotics (SA)
Number of subjects: 1688

Group type: COMPARATOR
Intervention: Gentamicin bone cement (GBC)
Number of subjects: 1688
Study: 7306432

Group type: EXPERIMENTAL
Intervention: Imipramine 50 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Imipramine 100 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Diazepam 10 mg
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Visual analogue scales for size and weight ratings
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Visual analogue scales expressing attitudes not directly related to mood
Number of subjects: 16
Study: 30379634

Group type: EXPERIMENTAL
Intervention: Virtual Reality Exposure (VRE)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Traditional Prolonged Exposure Therapy
Number of subjects: 108
Study: 28475831

Group type: EXPERIMENTAL
Intervention: Microarray-based immunoassay using the mimotope Clone A2 (peptide sequence VTPNDDTFDPFR)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Microarray-based immunoassay
Number of subjects: 0
Study: 25884155

Group type: EXPERIMENTAL
Intervention: Regorafenib (RE)
Number of subjects: 192

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 192
Study: 23657721

Group type: EXPERIMENTAL
Intervention: VAST
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control (10-cc syringe)
Number of subjects: 32
Study: 22004306

Group type: EXPERIMENTAL
Intervention: 8-session facilitated group cognitive behavioral therapy-based intervention
Number of subjects: 61

Group type: COMPARATOR
Intervention: Delayed treatment control
Number of subjects: 61
Study: 19681813

Group type: EXPERIMENTAL
Intervention: Tacrolimus QD
Number of subjects: 66

Group type: COMPARATOR
Intervention: Tacrolimus BID
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Tacrolimus QD and Tacrolimus BID
Number of subjects: 66
Study: 17948077

Group type: EXPERIMENTAL
Intervention: Traditional clipped-artery harvesting
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Modified nonclipped-artery harvesting
Number of subjects: 40
Study: 14687962

Group type: EXPERIMENTAL
Intervention: Methadone-maintained smokers
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control smokers
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control nonsmokers
Number of subjects: 36
Study: 11587113

Group type: EXPERIMENTAL
Intervention: Virtual reality (mean duration: 3.5, 4.9, and 6.4 minutes for sessions 1, 2, and 3 respectively)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control condition (no distraction)
Number of subjects: 7
Study: 10052670

Group type: EXPERIMENTAL
Intervention: Inhaled salbutamol (400 mcg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 7973119

Group type: EXPERIMENTAL
Intervention: Methazolamide treatment
Number of subjects: 6

Group type: COMPARATOR
Intervention: Fluorescein dye leakage
Number of subjects: 6
Study: 3335117

Group type: EXPERIMENTAL
Intervention: Nifedipine (24 micrograms/kg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nitrendipine (40 micrograms/kg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nisoldipine (10 micrograms/kg)
Number of subjects: 0
Study: 29803537

Group type: EXPERIMENTAL
Intervention: Preoperative chemoradiation followed by surgery and PHDRB (16-24 Gy) in unirradiated patients (n=25)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Surgery and PHDRB alone (32-40 Gy) in previously irradiated patients (n=25)
Number of subjects: 50
Study: 28281117

Group type: EXPERIMENTAL
Intervention: Game-enhanced curriculum (intervention)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Regular curriculum (control)
Number of subjects: 31
Study: 26252548

Group type: EXPERIMENTAL
Intervention: Caffeine supplementation (6 mg/kg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 23937064

Group type: EXPERIMENTAL
Intervention: Use of medical words by hospice team members
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Medical words used by caregivers and team members
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Medical words used by team members
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Caregivers' response to medical word use
Number of subjects: 0
Study: 21564160

Group type: EXPERIMENTAL
Intervention: Terutroban 2.5 mg
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Terutroban 5 mg
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Terutroban 10 mg
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 19232204

Group type: EXPERIMENTAL
Intervention: Enoxaparin (ENX)
Number of subjects: 191

Group type: COMPARATOR
Intervention: Non-fractionated Heparin (NFH)
Number of subjects: 191
Study: 17348237

Group type: EXPERIMENTAL
Intervention: Zhong tong'an combined with dexamethasone tablets
Number of subjects: 100

Group type: COMPARATOR
Intervention: Dexamethasone tablets alone
Number of subjects: 100
Study: 15087602

Group type: EXPERIMENTAL
Intervention: Tirofiban (10 microg/kg bolus followed by 0.15 microg/kg/min)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo bolus and infusion
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Tirofiban
Number of subjects: 32
Study: 10994902

Group type: EXPERIMENTAL
Intervention: Aerobic exercise program (30-60 min moderate-intensity running 3-5 times a week for 12-16 weeks)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Aerobic exercise program
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control (untrained)
Number of subjects: 56
Study: 9172024

Group type: EXPERIMENTAL
Intervention: sublingual buprenorphine 0.2 mg
Number of subjects: 342

Group type: COMPARATOR
Intervention: oral controlled release morphine 10 mg
Number of subjects: 342

Group type: COMPARATOR
Intervention: 0.25% bupivacaine (10 ml) wound infiltration
Number of subjects: 342
Study: 7712621

Group type: EXPERIMENTAL
Intervention: Pentoxifylline (600 mg daily for 5 days) + Aspirin (150 mg daily)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo + Aspirin (150 mg daily)
Number of subjects: 110
Study: 3438581

Group type: EXPERIMENTAL
Intervention: Sustained theophylline administration
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 31846392

Group type: EXPERIMENTAL
Intervention: Extraperitoneal approach
Number of subjects: 98
Study: 29537915

Group type: EXPERIMENTAL
Intervention: Four abbreviated exposures on day 1
Number of subjects: 0

Group type: COMPARATOR
Intervention: One extended split-belt exposure on day 1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Training for 4 consecutive days before testing on day 5
Number of subjects: 0
Study: 26683453

Group type: EXPERIMENTAL
Intervention: Daily positive affect among nonstudents
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Daily negative affect among nonstudents
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Daily negative affect among college students
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Weekend days
Number of subjects: 72
Study: 25712758

Group type: EXPERIMENTAL
Intervention: Surgical decompression of nerves in the lower extremity (tibial, superficial, deep and common peroneal nerves)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control leg (no intervention)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Surgical decompression of nerves in the lower extremity
Number of subjects: 42
Study: 23549864

Group type: EXPERIMENTAL
Intervention: Saxagliptin/metformin IR 2.5 mg/500 mg FDC tablet
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Saxagliptin/metformin IR 2.5 mg/1,000 mg FDC tablet
Number of subjects: 24

Group type: COMPARATOR
Intervention: Co-administration of saxagliptin 2.5 mg and metformin IR 500 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Co-administration of saxagliptin 2.5 mg and metformin IR 1,000 mg
Number of subjects: 24
Study: 20938315

Group type: EXPERIMENTAL
Intervention: Safe home model
Number of subjects: 371

Group type: COMPARATOR
Intervention: TIPP sheet
Number of subjects: 371
Study: 18450604

Group type: EXPERIMENTAL
Intervention: Multifaceted behavioral intervention
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 19
Study: 19942984

Group type: EXPERIMENTAL
Intervention: Pharmacotherapeutic Follow-up (PF) for 12 months
Number of subjects: 161

Group type: COMPARATOR
Intervention: Control group (no PF)
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Pharmacotherapeutic Follow-up (PF)
Number of subjects: 161
Study: 15895316

Group type: EXPERIMENTAL
Intervention: High concentration arginine aspartate (5.7 g arginine and 8.7 g aspartate)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Low concentration arginine aspartate (2.8 g arginine and 2.2 g aspartate)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 11552063

Group type: EXPERIMENTAL
Intervention: WBC-reduced RBCs matched for E, C, and Kell
Number of subjects: 130
Study: 9778005

Group type: EXPERIMENTAL
Intervention: Isoflurane (0.8 +/- 0.4%)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Desflurane (3.4 +/- 1.1%)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Normothermic patients
Number of subjects: 120

Group type: COMPARATOR
Intervention: Hypothermic patients
Number of subjects: 120
Study: 7823274

Group type: EXPERIMENTAL
Intervention: CR group (epithelial collar removed, graft sutured under facial flap)
Number of subjects: 30

Group type: COMPARATOR
Intervention: CTG group (epithelial collar preserved and left exposed)
Number of subjects: 30
Study: 3169046

Group type: EXPERIMENTAL
Intervention: Digoxin
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Diltiazem
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Calcium antagonists (Verapamil and Diltiazem)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Digitalized patients with AF
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 31273171

Group type: EXPERIMENTAL
Intervention: Docetaxel plus Ramucirumab with prophylactic pegfilgrastim
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Docetaxel plus Ramucirumab
Number of subjects: 10
Study: 28152178

Group type: EXPERIMENTAL
Intervention: Mini Mental State Examination (MMSE) at hospital admission, discharge, and at 3 and 12 months after discharge
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Mixed effects modeling
Number of subjects: 302
Study: 26795448

Group type: EXPERIMENTAL
Intervention: Manual therapy and supervised exercise (MTEX)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Advice and home exercise alone (Ad+HEP)
Number of subjects: 15
Study: 24041131

Group type: EXPERIMENTAL
Intervention: Combined buprenorphine-naloxone and behavioral treatment
Number of subjects: 22
Study: 22858452

Group type: EXPERIMENTAL
Intervention: Prednisolone at a dose of 2 mg/kg/day (first group: 40 attacks)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Prednisolone at a dose of 0.5 mg/kg/day (second group: 46 attacks)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Prednisolone at a dose of 0.5 mg/kg/day (second group)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Comparison of fever reduction and interval between attacks
Number of subjects: 41
Study: 19417228

Group type: COMPARATOR
Intervention: Euhydrated (EUH)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Hypohydrated1 (HYPO1)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Hypohydrated2 (HYPO2)
Number of subjects: 8
Study: 17377312

Group type: EXPERIMENTAL
Intervention: Audio/video narratives (UMTS based)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Audio only narrative (portable MP3)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Audio only narrative (CD at home)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Audio and video narrative (DVD at home)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study: 15250767

Group type: EXPERIMENTAL
Intervention: Caffeine intake
Number of subjects: 14
Study: 12003486

Group type: EXPERIMENTAL
Intervention: Braun Oral-B Battery toothbrush (D4)
Number of subjects: 48

Group type: COMPARATOR
Intervention: ADA manual toothbrush
Number of subjects: 48
Study: 9576634

Group type: EXPERIMENTAL
Intervention: CD4+ T-cell subsets in cerebrospinal fluid (CSF) and peripheral blood
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: CD4+ T-cell subsets in CSF
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: CD8+ T-cell subsets in CSF
Number of subjects: 73

Group type: COMPARATOR
Intervention: Distribution of activation markers in CSF and peripheral blood
Number of subjects: 73
Study: 7872722

Group type: EXPERIMENTAL
Intervention: TGF-beta 1
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: TGF-beta 2
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Correlation between TGF-beta 1 and TGF-beta 2
Number of subjects: 46
Study: 3207656

Group type: EXPERIMENTAL
Intervention: Local scleral buckling alone
Number of subjects: 84

Group type: COMPARATOR
Intervention: Combined local scleral buckling with encirclement
Number of subjects: 84
Study: 29530883

Group type: EXPERIMENTAL
Intervention: Lotus
Number of subjects: 912

Group type: COMPARATOR
Intervention: CoreValve
Number of subjects: 912

Group type: EXPERIMENTAL
Intervention: Lotus and CoreValve
Number of subjects: 912
Study: 27630085

Group type: EXPERIMENTAL
Intervention: Plasma IL-6
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Plasma IL-8
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Plasma IL-10
Number of subjects: 200
Study: 24103043

Group type: EXPERIMENTAL
Intervention: Incremental CPAP (4‐10 cmH2O)
Number of subjects: 37
Study: 24159691

Group type: EXPERIMENTAL
Intervention: Hysteroscopy before intrauterine insemination (IUI)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Ovulation induction by clomiphene citrate and hCG followed by IUI (Control group)
Number of subjects: 110
Study: 18410204

Group type: EXPERIMENTAL
Intervention: Expressive writing
Number of subjects: 69

Group type: COMPARATOR
Intervention: Control writing
Number of subjects: 69
Study: 16163912

Group type: EXPERIMENTAL
Intervention: Low-dose aprotinin (Group 2)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: High-dose aprotinin (Group 3)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (Group 1)
Number of subjects: 60
Study: 12226606

Group type: EXPERIMENTAL
Intervention: Laser structured base bracket (Discovery, Dentaurum)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Simple foil mesh bracket (Minitrim, Dentaurum)
Number of subjects: 120
Study: 10583311

Group type: EXPERIMENTAL
Intervention: 2 mg 17beta-oestradiol daily
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 8582471

Group type: EXPERIMENTAL
Intervention: Dexibuprofen 400 mg tablet formulation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dexibuprofen 200, 400, and 600 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ibuprofen racemate 400, 800, and 1200 mg
Number of subjects: 0
Study: 2118408

Group type: EXPERIMENTAL
Intervention: BCAA-enriched TPN (0.56 g BCAA kg‐1 body-weight, 50.2% BCAA)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Standard TPN (0.18 g BCAA kg‐1 body-weight, 15.6% BCAA)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: BCAA-enriched TPN
Number of subjects: 101

Group type: COMPARATOR
Intervention: Standard TPN
Number of subjects: 101
Study: 336379

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide and timolol
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide and amiloride
Number of subjects: 24

Group type: COMPARATOR
Intervention: Hydrochlorothiazide and placebo
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide and timolol and amiloride
Number of subjects: 24
Study: 29028762

Group type: EXPERIMENTAL
Intervention: Continuous infusion of morphine and midazolam
Number of subjects: 60

Group type: COMPARATOR
Intervention: Intermittent dosing only
Number of subjects: 60
Study: 27567239

Group type: EXPERIMENTAL
Intervention: Intravenous thrombolysis plus mechanical thrombectomy (IVTMT group)
Number of subjects: 414

Group type: COMPARATOR
Intervention: Intravenous thrombolysis alone (IVT group)
Number of subjects: 414

Group type: EXPERIMENTAL
Intervention: Both groups (IVT and IVTMT)
Number of subjects: 414

Group type: EXPERIMENTAL
Intervention: Mechanical thrombectomy related adverse events
Number of subjects: 414
Study: 25338640

Group type: EXPERIMENTAL
Intervention: Prebent reconstruction plates molded to MRP mandibular models
Number of subjects: 28

Group type: COMPARATOR
Intervention: Conventional reconstruction methods
Number of subjects: 28
Study: 22370531

Group type: EXPERIMENTAL
Intervention: CIC‐HFA 74 micrograms
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CIC‐HFA 148 micrograms
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 20864406

Group type: EXPERIMENTAL
Intervention: Continuation of imatinib treatment
Number of subjects: 434

Group type: COMPARATOR
Intervention: Interruption of imatinib treatment
Number of subjects: 434
Study: 18421069

Group type: EXPERIMENTAL
Intervention: Male-to-female transsexuals (group 3)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Males (group 1)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Females (group 2)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Female-to-male transsexuals (group 4)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Ghrelin levels
Number of subjects: 55
Study: 15812075

Group type: EXPERIMENTAL
Intervention: Maintenance vinorelbine (25 mg/m²/week for 6 months)
Number of subjects: 181

Group type: COMPARATOR
Intervention: Observation (no further treatment)
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Maintenance vinorelbine
Number of subjects: 181